Special Services
If you require special assistance to attend this event, please call Melissa Darsey at (859) 323-4573.
An Equal Opportunity University.
Speakers
Val Adams, Payton Atkins, Allison Butts, Timothy Mullett, Philip Schwieterman
Val Adams, Pharm.D
Associate Professor
Pharmacy Practice and Science
University of Kentucky
College of Pharmacy
Lexington, Kentucky
Dr. Adams is an Associate Professor in the department of Pharmacy Practice and Science in the College of Pharmacy at the University of Kentucky. He co-chairs the protocol review and monitoring committee for the Markey Cancer Center. He received his B.S. in pharmacy from the University of Utah and received his doctor of pharmacy from the University of Texas. He did an oncology residency at the Audie Murphy VA in San Antonio and an immunology fellowship at the University of Florida.
Payton Atkins, PharmD
PGY2 Hematology/Oncology Pharmacy Resident
University of Kentucky College of Pharmacy
Lexington, Kentucky
Payton Atkins is originally from Cincinnati, Ohio. She completed her Bachelors of Science in Nutrition and PharmD at the University of Kentucky. Payton completed her PGY1 Ambulatory Care Residency at the University of Kentucky HealthCare.
Allison Butts, PharmD, BCOP
Assistant Adjunct Professor
Pharmacy Practice and Science
University of Kentucky
College of Pharmacy
Clinical Coordinator
Medical Oncology
Markey Cancer Center Comprehensive Breast Care Center
Lexington, Kentucky
Dr. Butts received her Bachelor of Science in Molecular and Cellular Biology from the University of Illinois at Urbana-Champaign, and her Doctor of Pharmacy degree from the University of Kentucky. She then completed a PGY1 pharmacy practice residency at The Johns Hopkins Hospital and a PGY2 specialty residency in hematology/ oncology at the University of Kentucky Chandler Medical Center. Dr. Butts provides comprehensive pharmaceutical care to patients at UK’s Markey Cancer Center, primarily practicing in the Comprehensive Breast Care Center. Additionally, she serves as the PGY2 Hematology/Oncology Pharmacy Residency Program Director and is an Assistant Adjunct Professor at the University of Kentucky College of Pharmacy.
Teaching activities include precepting students and residents on ambulatory oncology rotations and the inpatient medical oncology service, and participating in the therapeutics curriculum. Her research interests include breast oncology, supportive care, financial toxicity, and optimizing residency training.
Timothy Mullett, MD, MBA, FACS
Professor, Division of Cardiothoracic Surgery
University of Kentucky College of Medicine
Medical Director, Network Operations
UK Markey Cancer Center
Lexington, Kentucky
Chair, Commission on Cancer
American College of Surgeons
Timothy Wm. Mullett, MD, MBA, FACS, is a professor of surgery in the Division of Cardiothoracic Surgery at the University of Kentucky (UK). He received his medical degree and surgical training at the University of Florida, and has served on faculty at UK for the past 25 years. Although he has experience in cardiac surgery and transplantation, Dr. Mullett’s clinical practice and research focuses on the overwhelming burden of lung cancer in Kentucky. He is a member of the UK Markey Cancer Center – Kentucky’s only National Cancer Institute-designated cancer center – and is chair of UK’s cancer committee. This Commission on Cancer program achieved an Outstanding Achievement Award in 2017. He served as CoC state chair for six years and was awarded Outstanding State Chair in 2019. In October of 2019, Dr. Mullett was elected to serve as the next national Chair of the CoC, a role he assumed in November 2020.
Currently, Dr. Mullett is the medical director of the Markey Cancer Center Affiliate Network, a program that provides high-quality cancer care closer to home at collaborating centers through specialty services, education and outreach programs. He also serves as medical director of the Markey Cancer Center Research Network, a collaborative network of sites that conducts a portfolio of high priority trials including therapeutic oncology trials and interventional and non-interventional studies appropriate for community centers.
Dr. Mullett’s research interests include studying quality implementation of lung cancer screening. He is principal investigator of the Kentucky LEADS Collaborative, a portfolio of studies to reduce the burden of lung cancer in Kentucky. For three years, he has been the clinical champion for the L.A.U.N.C.H. Collaborative, working with the NCI, the Federal Communications Commission, Amgen, and other stakeholders to study barriers to cancer care and the impact of limited broadband access.
In addition to his medical career, Dr. Mullett is a retired colonel with 27 years in the US Army Reserves Medical Corps, with tours of duty in Iraq, Afghanistan and with Homeland Security in response to terrorist threats. He is also an eight-year cancer survivor, having been treated successfully with targeted therapy for a metastatic sarcoma.
Philip Schwieterman, PharmD, MHA
Adjunct Assistant Professor
University of Kentucky
College of Pharmacy
Director of Oncology and Pediatric Pharmacy Services
UK HealthCare
Lexington, Kentucky
Philip Schwieterman obtained his bachelors and doctorate of pharmacy degrees from The Ohio State University and his Master of Health Administration from the University of Kentucky. Philip joined UK HealthCare as a Pharmacy Director in 2013 where he has led numerous financial, clinical, and operational initiatives surrounding the growth and oversight of oncology, infusion, specialty and pediatric pharmacy services. He currently serves as the Pharmacy Director for Oncology and Pediatrics.
